Mitochondria Cleanup Pill Shocks Scientists

A pomegranate-derived compound called Urolithin A has now been tested in more than two dozen human clinical trials, and the data keep pointing the same direction: it helps aging cells clean out worn-out mitochondria and rebuild stronger ones.

Quick Take

Urolithin A, sold as Mitopure, triggers mitophagy, the process where cells clear damaged mitochondria and grow healthier ones.
A 2022 randomized, placebo-controlled trial found middle-aged adults gained muscle strength and exercise performance after four months on the supplement.
A newer trial published in Nature Aging showed four weeks of use improved immune cell function and lowered inflammation markers in adults 45 to 70.
Timeline, the company behind Mitopure, has now run 25 human trials, including a 650-person study on brain health and longevity.

What Mitophagy Actually Means For Aging Bodies

Mitochondria are the tiny power plants inside every cell. As people age, these power plants get damaged and stop clearing out efficiently. That buildup of broken mitochondria is linked to fatigue, weaker muscles, and slower recovery. Mitophagy is the cellular cleanup crew that removes the damaged units. Urolithin A is one of the few natural compounds shown in human trials to switch that cleanup process back on.

The compound itself isn’t swallowed directly from pomegranates. It’s produced when gut bacteria break down plant compounds called ellagitannins, found in pomegranates, walnuts, and berries. Not everyone’s gut bacteria make enough of it naturally, which is why researchers built a standardized supplement version, Mitopure, to guarantee a consistent dose in trials.

The Muscle And Exercise Data Behind The Claim

The clearest functional evidence comes from a 2022 trial in middle-aged adults. Researchers gave participants two different doses of Mitopure for four months against a placebo, tracking mitochondrial biomarkers alongside strength testing. The published results showed measurable gains in muscle strength and exercise performance, not just shifts in blood markers, giving the trial more real-world weight than earlier bioavailability studies alone.

That built on a 2019 first-in-human study, which established that the compound was safe and reached the bloodstream at doses that changed mitochondrial and cellular health markers in elderly, sedentary adults. That early trial was the proof-of-concept step. It didn’t test strength or performance directly, but it confirmed the biology worked in aging human bodies, not just in mice.

New Trial Data Points To Immune System Benefits

A newer study, published in Nature Aging and known as MitoImmune, tested 50 healthy adults ages 45 to 70 over 28 days. Participants took 1,000 milligrams of Urolithin A or a placebo daily. Researchers tracked immune cell composition and inflammation markers, both of which tend to worsen with age and drive up disease risk in older adults.

The results showed the supplement group had more youthful, active immune cells, including a boost in a protective type of white blood cell called CD8 T-cells, along with reduced markers of immune exhaustion. Inflammatory markers tied to chronic disease risk, including CRP and IL-6, also dropped in the supplemented group compared to placebo.

A Growing Research Program, Not A Single Study

Timeline, the company developing Mitopure, has now completed 25 human clinical trials on the compound, more than almost any other longevity supplement on the market. Its latest study enrolls 650 participants and focuses on brain health and long-term aging outcomes, making it the largest Urolithin A trial to date. The federal government’s clinical trials registry also lists active studies testing the compound for glucose metabolism and blood flow in older adults.

Independent research groups agree the safety picture has held up well across studies, with no serious adverse events reported in trial after trial. As with most nutrition science, the strongest current evidence centers on biomarkers like mitochondrial function and muscle endurance, while long-term outcomes such as disease prevention will take further large-scale study to confirm.

Urolithin A is a compound produced in the gut by microbial metabolism of ellagitannins, the polyphenols found in pomegranates, walnuts, and some berries. Not everyone produces it efficiently. Gut microbiome composition determines whether you convert ellagitannins into urolithin A… pic.twitter.com/CklKjPNLsg

— Capsuline (@capsuline) August 9, 2026

For readers watching their own energy and strength decline with age, the appeal is obvious: a naturally occurring compound, tested in randomized, placebo-controlled trials, that appears to help cells do what they used to do on their own. That’s a rare thing in the supplement aisle, where marketing usually outruns the science by years.